These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 10499910)

  • 1. The use of prothrombin complex concentrates in the treatment of hemorrhages induced by oral anticoagulation.
    Pindur G; Mörsdorf S
    Thromb Res; 1999 Aug; 95(4 Suppl 1):S57-61. PubMed ID: 10499910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study.
    Sarode R; Milling TJ; Refaai MA; Mangione A; Schneider A; Durn BL; Goldstein JN
    Circulation; 2013 Sep; 128(11):1234-43. PubMed ID: 23935011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four-factor prothrombin complex concentrate versus plasma for urgent vitamin K antagonist reversal: new evidence.
    Sarode R
    Clin Lab Med; 2014 Sep; 34(3):613-21. PubMed ID: 25168946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-Analysis of Reversal Agents for Severe Bleeding Associated With Direct Oral Anticoagulants.
    Gómez-Outes A; Alcubilla P; Calvo-Rojas G; Terleira-Fernández AI; Suárez-Gea ML; Lecumberri R; Vargas-Castrillón E
    J Am Coll Cardiol; 2021 Jun; 77(24):2987-3001. PubMed ID: 34140101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding.
    Schick KS; Fertmann JM; Jauch KW; Hoffmann JN
    Crit Care; 2009; 13(6):R191. PubMed ID: 19948037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of urgent warfarin reversal with frozen plasma versus prothrombin complex concentrate in the emergency department.
    Hickey M; Gatien M; Taljaard M; Aujnarain A; Giulivi A; Perry JJ
    Circulation; 2013 Jul; 128(4):360-4. PubMed ID: 23770745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergency reversal of anticoagulation: from theory to real use of prothrombin complex concentrates. A retrospective Italian experience.
    Barillari G; Pasca S; Barillari A; De Angelis V
    Blood Transfus; 2012 Jan; 10(1):87-94. PubMed ID: 22044952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of a prothrombin complex concentrate (Octaplex) for rapid reversal of oral anticoagulation.
    Lubetsky A; Hoffman R; Zimlichman R; Eldor A; Zvi J; Kostenko V; Brenner B
    Thromb Res; 2004; 113(6):371-8. PubMed ID: 15226091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal Agents for the Direct Oral Anticoagulants.
    Ansell JE
    Hematol Oncol Clin North Am; 2016 Oct; 30(5):1085-98. PubMed ID: 27637309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy.
    Makris M; Greaves M; Phillips WS; Kitchen S; Rosendaal FR; Preston EF
    Thromb Haemost; 1997 Mar; 77(3):477-80. PubMed ID: 9065997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prothrombin complex concentrates as reversal agents for new oral anticoagulants: lessons from preclinical studies with Beriplex.
    Dickneite G
    Clin Lab Med; 2014 Sep; 34(3):623-35. PubMed ID: 25168947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding and antidotes in new oral anticoagulants.
    Majeed A; Schulman S
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):191-202. PubMed ID: 23953907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The overdosed patient and bleedings with oral anticoagulation.
    Pindur G; Mörsdorf S; Schenk JF; Krischek B; Heinrich W; Wenzel E
    Semin Thromb Hemost; 1999; 25(1):85-8. PubMed ID: 10327226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative use of prothrombin complex concentrates.
    Colomina MJ; Díez Lobo A; Garutti I; Gómez-Luque A; Llau JV; Pita E
    Minerva Anestesiol; 2012 Mar; 78(3):358-68. PubMed ID: 22357373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation.
    Riess HB; Meier-Hellmann A; Motsch J; Elias M; Kursten FW; Dempfle CE
    Thromb Res; 2007; 121(1):9-16. PubMed ID: 17407788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.
    Le Roux P; Pollack CV; Milan M; Schaefer A
    J Neurosurg; 2014 Aug; 121 Suppl():1-20. PubMed ID: 25081496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New strategies for effective treatment of vitamin K antagonist-associated bleeding.
    Yates SG; Sarode R
    J Thromb Haemost; 2015 Jun; 13 Suppl 1():S180-6. PubMed ID: 26149021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic interventions for reversing the effects of oral anticoagulants.
    Kalus JS
    Am J Health Syst Pharm; 2013 May; 70(10 Suppl 1):S12-21. PubMed ID: 23640528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid reversal of warfarin-associated hemorrhage in the emergency department by prothrombin complex concentrates.
    Frumkin K
    Ann Emerg Med; 2013 Dec; 62(6):616-626.e8. PubMed ID: 23829955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing a management plan for oral anticoagulant reversal.
    Dager WE
    Am J Health Syst Pharm; 2013 May; 70(10 Suppl 1):S21-31. PubMed ID: 23640529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.